Alsoussi, Wafaa B.
Malladi, Sameer Kumar http://orcid.org/0000-0001-5131-4518
Zhou, Julian Q. http://orcid.org/0000-0001-9602-2092
Liu, Zhuoming http://orcid.org/0000-0001-8198-0976
Ying, Baoling
Kim, Wooseob http://orcid.org/0000-0002-9199-1000
Schmitz, Aaron J. http://orcid.org/0000-0002-8077-6751
Lei, Tingting
Horvath, Stephen C.
Sturtz, Alexandria J.
McIntire, Katherine M.
Evavold, Birk
Han, Fangjie
Scheaffer, Suzanne M.
Fox, Isabella F.
Mirza, Senaa F. http://orcid.org/0000-0003-3319-5388
Parra-Rodriguez, Luis
Nachbagauer, Raffael
Nestorova, Biliana
Chalkias, Spyros
Farnsworth, Christopher W.
Klebert, Michael K.
Pusic, Iskra
Strnad, Benjamin S. http://orcid.org/0000-0003-2308-1299
Middleton, William D.
Teefey, Sharlene A.
Whelan, Sean P. J. http://orcid.org/0000-0003-1564-8590
Diamond, Michael S. http://orcid.org/0000-0002-8791-3165
Paris, Robert
O’Halloran, Jane A. http://orcid.org/0000-0001-8265-9471
Presti, Rachel M. http://orcid.org/0000-0002-5469-0727
Turner, Jackson S. http://orcid.org/0000-0002-4396-6265
Ellebedy, Ali H. http://orcid.org/0000-0002-6129-2532
Article History
Received: 22 September 2022
Accepted: 28 March 2023
First Online: 3 April 2023
Competing interests
: The Ellebedy laboratory and Infectious Disease Clinical Research Unit has received funding under sponsored research agreements from Moderna related to the data presented in the current study. The Ellebedy laboratory received funding from Emergent BioSolutions and AbbVie that are unrelated to the data presented in the current study. A.H.E. has received consulting and speaking fees from InBios International, Fimbrion Therapeutics, RGAX, Mubadala Investment Company, Moderna, Pfizer, GSK, Danaher, Third Rock Ventures, Goldman Sachs and Morgan Stanley and is the founder of ImmuneBio Consulting. W.B.A., A. J. Schmitz, S.P.J.W., M.S.D., J.S.T. and A.H.E. are recipients of a licensing agreement with Abbvie that is unrelated to the data presented in the current study. M.S.D. is a consultant for Inbios, Vir Biotechnology, Senda Biosciences, Moderna, Sterne-Kessler and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology, Emergent BioSolutions and Moderna. S.P.J.W. is a consultant for Thylacine Bio. S.P.J.W. is a recipient of a licensing agreement with Vir Biotechnology and Merck. The Whelan laboratory has received unrelated funding support in sponsored research agreements from Vir Biotechnology. R.P., B.N., S.C. and R.N. are employees of and shareholders in Moderna. The other authors declare no competing interests.
Free to read: This content has been made available to all.